Stocks
Atara Biotherapeutics (ATRA) Net margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| Net margin, % | ? | -1 672% | -359.1% | -3 221% | -66.2% | 27.1% | -40.9% | |
| Changes by years, y/y, % | +1 313pp | -2 862pp | +3 155pp | +93pp | ||||
Atara Biotherapeutics. Net margin, %
Atara Biotherapeutics. Net margin, changes, pp
Atara Biotherapeutics (ATRA) Net margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| Net margin, % | ? | 13.6% | -124.6% | -213.5% | -803.3% | -936.8% | -40.9% | |
| Changes by years, y/y, % | +80pp | -70pp | -175pp | -842pp | -950pp | |||
| Changes by quarters, q/q, % | -25pp | -138pp | -89pp | -590pp | -134pp | |||
